|
Title
|
|
|
|
Clinical pharmacology of the novel marine-derived anticancer agent Ecteinascidin 743 administered as a 1- and 3-h infusion in a phase I study
| |
|
Author
|
|
|
|
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Anti-cancer drugs: an international journal on anti-cancer agents. - Philadelphia, Pa
| |
|
Publication
|
|
|
|
Philadelphia, Pa
:
2002
| |
|
ISSN
|
|
|
|
0959-4973
| |
|
DOI
|
|
|
|
10.1097/00001813-200204000-00007
| |
|
Volume/pages
|
|
|
|
13
(2002)
, p. 381-393
| |
|
ISI
|
|
|
|
000175307000007
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|